It must be nice to be the CEO of a life sciences company that sells itself. When Tina Nova stepped up to the microphone at the Roth Capital Partners Growth Stock Conference in Laguna Niguel, CA, yesterday, the Genoptix CEO was playing to a nearly full house. Investors and analysts occupied all but two or … Continue reading “Founding CEO Tina “Super” Nova Keeps Genoptix On a Roll”
Xconomy Forum: How Information Technology is Transforming Medicine and Healthcare
Healthcare IT has been near the top of the U.S. agenda since January 2009, when President Obama set a goal of making all of the nation’s health records computerized within five years. The administration poured in $19 billion from the economic stimulus program to support electronic medical records a few months later. Yet many healthcare … Continue reading “Xconomy Forum: How Information Technology is Transforming Medicine and Healthcare”
How to Reconnect at the the Right Time: Entrepreneur’s Personal Project Evolves into an E-mail Reminder Service
When Chris Keller was working full-time at his startup, the online celebrity fantasy league site Fafarazzi.com, he had plenty of e-mails that needed following up on, as most entrepreneurs do. He’d set reminders for himself on his calendar, but found this mechanism wasn’t ideal, since it was tedious to modify every calendar entry to reflect … Continue reading “How to Reconnect at the the Right Time: Entrepreneur’s Personal Project Evolves into an E-mail Reminder Service”
Sequenom Speaks Out, Amylin Receives a Setback, Somaxon Awaits FDA Decision, & More San Diego Life Sciences News
Regulatory news dominated the headlines in the past week. We have it summarized for you here. —Sequenom (NASDAQ: [[ticker:SQMN]]) said a lack of adequate controls, protocols and supervision were to blame for the mishandled data that led the company to scrub its launch of a diagnostic test for Down syndrome. Sequenom shares lost 76 percent … Continue reading “Sequenom Speaks Out, Amylin Receives a Setback, Somaxon Awaits FDA Decision, & More San Diego Life Sciences News”
Boston-Area Tech Tells People to Take Their Meds, Targets Billions in Wasted Healthcare Spending
It’s tough to find an excuse for forgetting to take your medications nowadays. And if you’re thinking of a good excuse right now, chances are that companies and technologists in the Boston area have already addressed it with an information technology invention. Poor adherence to medications has been a bugaboo in the healthcare system for … Continue reading “Boston-Area Tech Tells People to Take Their Meds, Targets Billions in Wasted Healthcare Spending”
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News
I was happy to meet many regular readers during a two-day frenzy of networking, reporting, and writing at the Life Sciences Innovation Northwest meeting. Sleep is now moving up the priority list, so my conference wrap up will have to wait a few more hours. But until then, here’s a recap on the last week … Continue reading “Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News”
ULocate is Where, Now? Exactly
Okay, bad joke in the headline. But there’s some real news behind it. The Boston startup formerly called uLocate, long known mainly as the creator of the GPS-based Where local search app for mobile phones, announced yesterday that it has taken the app’s name as its own. The change “creates a more coherent message for … Continue reading “ULocate is Where, Now? Exactly”
Elcelyx Therapeutics Garners $1,200,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b52c86e-a436-4649-be61-769ea6f6129c&Preview=1 Date 3/18/2010 Company Name Elcelyx Therapeutics Mailing Address 12730 High Bluff Dr San Diego, CA 92130 Company Description Elcelyx Therapeutics of San Diego is a stealth mode diabetes related biotechnology company. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,200,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Elcelyx Therapeutics Garners $1,200,000 New Funding Round”
Plastic Jungle Receives $7,400,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9fdfbee2-6f52-4633-8957-7a024455e52d&Preview=1 Date 3/18/2010 Company Name Plastic Jungle Mailing Address 2491 Alluvial Ave Clovis, CA 93611 Company Description Plastic Jungle is the leading Web site for gift card exchanges — whether you want to buy gift cards at substantial savings, sell them for cash, or trade pre-owned gift cards with others, www.plasticjungle.com offers … Continue reading “Plastic Jungle Receives $7,400,000 Series B Financing Round”
Formspring.me Obtains $2,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2db04034-c033-4651-871d-c3b64cab2cc7&Preview=1 Date 3/18/2010 Company Name Formspring.me Mailing Address 6525 E. 82nd St Indianapolis, IN 46250 Company Description The Formspring.me product is still quite simple, enabling users to create a page inviting people to ask them anything, even anonymously. Wechsler said the company’s first priority is keeping up with infrastructure demands; it currently … Continue reading “Formspring.me Obtains $2,500,000 New Funding Round”
Yahoo! Acquires Citizen Sports for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a72f476-f29c-45f4-88f7-9292e1cbe7b6&Preview=1 Date 3/18/2010 Company Name Citizen Sports Mailing Address 525 Brannan Street San Francisco, CA 94107-1632 Company Description That’s why you’ll find our products where you already spend time with your friends (like inside your favorite social networking sites). From fantasy football to filling out a bracket to cheering for a favorite … Continue reading “Yahoo! Acquires Citizen Sports for Undisclosed Sum”
Smartling Receives $4,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aaf70ec9-c7ba-44b4-9993-3e1aa32a7189&Preview=1 Date 3/18/2010 Company Name Smartling Mailing Address 15 Jennifer Lane Rye Brook, NY 10573 Company Description The web is world-wide, but English isn’t. Research shows most people won’t buy from sites that aren’t in their native tongues. Smartling makes it easy to create multilingual sites — and turn global visitors into … Continue reading “Smartling Receives $4,000,000 Series A Funding Round”
Trada Receives $2,200,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8a64c278-4237-4846-a7df-f6b79277f7bd&Preview=1 Date 3/18/2010 Company Name Trada Mailing Address 1023 Walnut Street Boulder, CO 80302 Company Description Trada is revolutionizing the way Agencies, Advertisers and PPC Experts build and manage PPC marketing campaigns. We’ve developed the first PPC marketplace that allows agencies and in-house advertisers to leverage the skills of hundreds of the … Continue reading “Trada Receives $2,200,000 Series A Funding”
Xconomy Forum: Healthcare In Transition
An avalanche of advances in information technology is poised to reshape the healthcare landscape, and the Boston area, home to one of the world’s greatest concentrations of medical research institutions and technology innovators, is at the forefront of this transformation. The innovations afoot extend far beyond electronic medical records and other efforts to make traditional … Continue reading “Xconomy Forum: Healthcare In Transition”
How Will Information Technology Transform Healthcare? Xconomy Seeks Answers May 12
Entrepreneurs have been trying to kill off pen and paper with software for the healthcare industry for at least a decade. But it has really only leaped toward the top of the U.S. political agenda since January 2009, when President Obama said he wanted the nation’s health records to go electronic within five years. A … Continue reading “How Will Information Technology Transform Healthcare? Xconomy Seeks Answers May 12”
VCs On Politics: Officials Who Say They Love Innovation Are Actually Suffocating It
An idea virus swept through Washington DC and state capitals around the U.S. like a pandemic last year. Every elected official in front of a microphone suddenly wanted to spur innovation. Then they started pushing policies that will greatly undermine it. Bob Nelsen, the managing director of Arch Venture Partners, didn’t pull any punches during … Continue reading “VCs On Politics: Officials Who Say They Love Innovation Are Actually Suffocating It”
Acucela Gets FDA Fast Track
Acucela and its partner, Japan-based Otsuka Pharmaceutical, said today they have received “Fast Track” designation for an application to market a new drug for the “dry” form of age-related macular degeneration. The designation means that the companies will be able to file data on their drug, ACU-4429, as it becomes available, and which makes it … Continue reading “Acucela Gets FDA Fast Track”
Obama’s Health IT Chiefs on Tap for Governor Patrick’s Big Health Technology Ball
Massachusetts is going to be the focus of the health IT universe late next month — if it isn’t already. Governor Deval Patrick and his staff have invited power players in both the healthcare and technology fields to Boston in April for a conference that is expected to highlight the state’s fast-growing health IT sector. … Continue reading “Obama’s Health IT Chiefs on Tap for Governor Patrick’s Big Health Technology Ball”
San Diego’s Sequenom Steps Back Into the Spotlight, Sort Of
San Diego-based Sequenom (NASDAQ: [[ticker:SQNM]]) is entering a critical phase in its management of the corporate crisis that erupted in its laboratories last year. It’s stepping back into the spotlight. As a public company, Sequenom doesn’t have much choice. The maker of genetic diagnostic equipment and supplies says in its latest annual report that as … Continue reading “San Diego’s Sequenom Steps Back Into the Spotlight, Sort Of”
U.S. Chief Humanitarian: We Want to Buy Your Health Products For Poor Countries
The guy whose job is to make sure the U.S. is the world’s leading humanitarian showed up yesterday in Seattle to talk to a bunch of venture capitalists and biotech entrepreneurs. If that sounds odd, it should. But this is Seattle, home of the Bill & Melinda Gates Foundation and a cluster of hard-charging social … Continue reading “U.S. Chief Humanitarian: We Want to Buy Your Health Products For Poor Countries”
Second Porch Raises $1M
Portland, OR-based Second Porch, an Internet startup that lets people rent and trade vacation homes through social networks, announced today it has closed $1 million in Series A financing, led by the Oregon Angel Fund. The company has a Facebook application that lets consumers discover their friends’ vacation rental homes and helps homeowners find trusted … Continue reading “Second Porch Raises $1M”
Somaxon Eagerly Awaits (Another) FDA Ruling on Insomnia Drug
[Updated: 11:45 am Eastern, 3/17/10] Who was it that once said ‘if at first you don’t succeed, try, try again?’ This Friday, San Diego-based Somaxon expects find out from the FDA whether its persistence has paid off, and whether its insomnia drug is finally ready to be cleared for sale on the U.S. market. The … Continue reading “Somaxon Eagerly Awaits (Another) FDA Ruling on Insomnia Drug”
Cozi, Climbing Ranks of Consumer Software, Looks to Deliver on Family-Focused Vision in Mobile Market
As Don Corleone said in The Godfather, “A man who doesn’t spend time with his family can never be a real man.” If that’s true, then a Seattle company called Cozi should help quite a few people become real men. Cozi is a tech startup focused on family-related software for the home. That includes things … Continue reading “Cozi, Climbing Ranks of Consumer Software, Looks to Deliver on Family-Focused Vision in Mobile Market”
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News
New England’s life sciences and software companies kept us busy with news of early venture rounds, IPOs, and partnerships. —Battery Ventures, with offices locally in Waltham, MA, announced the close of its ninth fund, at $750 million. Existing limited partners account for about 85 percent of the fund’s investors, said the firm, which also has … Continue reading “Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News”
Second Porch Receives $1,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=110664b3-d28e-4566-8b56-b5ccfdd04f7a&Preview=1 Date 3/17/2010 Company Name Second Porch Mailing Address 2114 Ne 36th Avenue Portland, OR 97212 Company Description Second Porch is a completely new concept in the explosively growing vacation rental marketplace based on a simple idea: people should consider renting to and from the people they know and trust, And owners … Continue reading “Second Porch Receives $1,000,000 Series A Financing Round”
iGuiders Secures $700,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60494ed8-cedb-46c8-b8c6-51d68e70bc81&Preview=1 Date 3/17/2010 Company Name iGuiders Mailing Address 29526 Bryce Road Cleveland, OH 44124 Company Description iGuiders™ was born out of a desire to vastly improve the internet search experience. It was founded by Jodi Marchewitz, an expert in Internet research. Jodi spent years consulting with companies on implementing marketing strategy, tactics … Continue reading “iGuiders Secures $700,000 New Financing Round”
CollabNet Garners $5,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ae06969e-df53-43c7-be69-01cdcc2037ef&Preview=1 Date 3/17/2010 Company Name CollabNet Mailing Address 8000 Marina Boulevard Brisbane, CA 94005-1865 Company Description CollabNet is the leading provider of distributed software development solutions. Our solutions help corporations reduce costs, increase revenues, and capture market loyalty by bringing together software development teams, regardless of geographic location. Website http://www.collab.net Transaction Type … Continue reading “CollabNet Garners $5,000,000 New Funding Round”
Odyssey Thera Receives $3,500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8946c464-5bea-4da0-9528-33993df18d65&Preview=1 Date 3/17/2010 Company Name Odyssey Thera Mailing Address 4550 Norris Canyon Road San Ramon, CA 94583 Company Description Odyssey Thera Inc. is a drug discovery company that has developed a global cellular pharmacology strategy for the identification of safe and effective medicines for a wide spectrum of human diseases. Website http://www.odysseythera.com … Continue reading “Odyssey Thera Receives $3,500,000 New Financing”
Aurora Biofuels Lands $15,000,000 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37527e92-496d-42c2-b2c0-434bcc90543f&Preview=1 Date 3/17/2010 Company Name Aurora Biofuels Mailing Address 1301 Harbor Bay Parkway Alameda, CA 94502 Company Description Aurora BioFuels is a Berkeley, CA based innovative alternative energy company with a revolutionary method of creating bio-diesel. Aurora’s proprietary technology, developed at The University of California, Berkeley, allows Aurora BioFuels to create bio-diesel … Continue reading “Aurora Biofuels Lands $15,000,000 Series C Funding Round”
Nuon Therapeutics Secures $6,050,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5db6b8cc-5729-41dc-ac5e-800355cdd8ea&Preview=1 Date 3/17/2010 Company Name Nuon Therapeutics Mailing Address 2755 Campus Drive San Mateo, CA 94403 Company Description Nuon Therapeutics Inc., located in the San Francisco Bay Area, is focused on the development and commercialization of new therapies in inflammation and neurological diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and neuropathic … Continue reading “Nuon Therapeutics Secures $6,050,000 New Funding Round”
Solar Junction Receives $13,330,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c1764c78-cbc3-47c0-916d-de35ca5f932b&Preview=1 Date 3/17/2010 Company Name Solar Junction Mailing Address 401 Charcot Avenue San Jose, CA 95131 Company Description Solar Junction’s mission is to develop and supply the highest-efficiency solar cells enabling significant growth for the CPV market. These cells poses’s the highest efficiency for III-V terrestrial solar cells combined with the highest … Continue reading “Solar Junction Receives $13,330,000 Series C Round”
Panvidea Secures $2,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ca2dfa7a-1a01-409c-9487-51e91240a4eb&Preview=1 Date 3/17/2010 Company Name Panvidea Mailing Address 245 W 17th Street New York, NY 10011 Company Description Panvidea is a global leader in the preparation, processing and distribution of professional entertainment and advertising content across any digital platform. Originally founded as mPOINT in November 2007, the company re-branded in Spring 2010 … Continue reading “Panvidea Secures $2,000,000 Series A Financing”
Cadre Technologies Obtains New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=31b4280c-6916-42a0-9735-cd6916773a74&Preview=1 Date 3/17/2010 Company Name Cadre Technologies Mailing Address 7900 E. Union Ave. Denver, CO 80237 Company Description Cadre Technologies, Inc. is a leading innovator of integrated, automated solutions for the fulfillment and distribution industries. Website http://www.cadretech.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes The funding will … Continue reading “Cadre Technologies Obtains New Financing”
San Diego’s EMN8 Raises $14.4M For Self-Service Sales Kiosks
San Diego-based EMN8, which develops self-service, touchscreen displays and systems for use in fast-food restaurants, theaters, theme parks, and other retailers, has ordered up more than $14.4 million in venture funding, according to a recent filing with government regulators. The venture-backed company says it has raised all but $179,550 of a secondary round that began … Continue reading “San Diego’s EMN8 Raises $14.4M For Self-Service Sales Kiosks”
Amazon, Bing Team Up with Twitter
Twitter, the San Francisco-based micro-messaging company, announced it has developed a new set of frameworks to let consumers tweet, and follow others’ tweets, from within other websites outside of Twitter.com. Initial launch partners for the service, called “@anywhere,” include Seattle-area sites Amazon.com, Microsoft’s Bing, and MSNBC.com. Financial details of the partnerships weren’t given. Other big … Continue reading “Amazon, Bing Team Up with Twitter”
Swaptree Raises $4.8 Million
Swaptree, a Boston startup whose website allows members to trade used books, DVDs, CDs, and video games, has raised $4.8 million out of a planned $6 million offering involving equity, options, and warrants, according to a regulatory filing published today. Swaptree’s $3.35 million Series C financing round in September 2008 came from Safeguard Scientifics of … Continue reading “Swaptree Raises $4.8 Million”
A Chat with Susan Sigl, Incoming CEO of Washington Technology Industry Association
By now, you may have heard that Susan Sigl has been named as the successor to Ken Myer as head of the Washington Technology Industry Association (WTIA). This is one of the largest trade associations in the U.S., representing 1,000 members and some 125,000 employees in the technology sector. This morning, I had a chat … Continue reading “A Chat with Susan Sigl, Incoming CEO of Washington Technology Industry Association”
Adapt or Die, Biotechies: Steve Burrill on the Transformation of the Health Care Business
[Updated: 5:15 pm, 3/17/10] Biotechies, of all people, ought to relate to an old quote often attributed to Charles Darwin. It’s the one about how the strongest and most intelligent aren’t necessarily the ones who survive—it’s the ones who are most adaptable to change. That was the closest thing to a single theme running through … Continue reading “Adapt or Die, Biotechies: Steve Burrill on the Transformation of the Health Care Business”
Ventana Capital’s Tom Gephart Seeks $5 Billion (With a “B”) from Feds to Support VCs
You could say Tom Gephart is “old school” venture capital, which means he started investing in the 1970s when there were no rules. So maybe it shouldn’t seem too surprising when he says he’s working on a proposal to secure $5 billion in federal economic stimulus funding that would be invested in startup companies throughout … Continue reading “Ventana Capital’s Tom Gephart Seeks $5 Billion (With a “B”) from Feds to Support VCs”
Susan Sigl Is New WTIA CEO
The Washington Technology Industry Association announced today that it has named Susan Sigl its new CEO. Sigl is a former venture capitalist and an expert in mobile technology, financial services, and real estate. She is a founding partner of SeaPoint Ventures and helped found, fund, or manage many Northwest companies, including Ground Truth, SnapIn Software, … Continue reading “Susan Sigl Is New WTIA CEO”
Tekmira Cuts Deal With Pfizer
Tekmira Pharmaceuticals, the Vancouver, BC-based developer of RNA interference drugs, said today it has formed a partnership with New York-based Pfizer (NYSE: [[ticker:PFE]]) to use its lipid-nanoparticle technology as a delivery vehicle for Pfizer’s RNAi drug candidates. Tekmira will make the drug formulations, while Pfizer will run the animal tests. This marks the latest significant … Continue reading “Tekmira Cuts Deal With Pfizer”
$8M Series B for CorrelSense
Framingham, MA-based CorrelSense, which makes software that tracks business transactions and helps companies improve the performance of large enterprise applications, has collected $8 million in Series B venture funding, according to an announcement today. Accel Partners led the round, with existing investors Vertex Venture Capital, eXceed Technology and ProSeed Ventures joining in. The company says … Continue reading “$8M Series B for CorrelSense”
Google Apps Teams Up with Local Firms, Evri and Twine Merge, WildTangent Goes Social, & More Seattle-Area Deals News
New deals are in bloom as we await the arrival of spring in the Northwest. In the past week, we’ve seen a modest amount of activity in business software, Internet, gaming, health IT, and biotech. —Seattle-based Presage Biosciences has raised $3.1 million from unnamed individual investors, as Luke reported today. Presage, a spinoff from the … Continue reading “Google Apps Teams Up with Local Firms, Evri and Twine Merge, WildTangent Goes Social, & More Seattle-Area Deals News”
Ship Web 2.0 Features Early, and Don’t Fear User Hatred, Investor Dave McClure Tells Dogpatch Labs Audience
“Ship early, ship buggy,” was the advice San Francisco-based Web 2.0 investor Dave McClure gave to his audience at Cambridge, MA’s Dogpatch Labs last week. “The world is filled with products that shipped too late,” he continued. One example? The online budget-tracking service, Mint.com, a company McClure invests in along with other sites such as … Continue reading “Ship Web 2.0 Features Early, and Don’t Fear User Hatred, Investor Dave McClure Tells Dogpatch Labs Audience”
For Biotech and Pharma, Emerging Markets Offer Great Potential and Require New Strategies, Panelists Say
Emerging markets present an important opportunity for U.S. pharmaceutical and biotechnology firms. This was one of the take-home messages from the annual MIT Sloan BioMedical BioInnovations conference, which drew about 250 people to the Marriot Hotel in Cambridge last Friday. In a panel discussion, Jonathan Fleming, the managing general partner of Oxford Bioscience Partners, said … Continue reading “For Biotech and Pharma, Emerging Markets Offer Great Potential and Require New Strategies, Panelists Say”
Presage, a Hutch Spinoff, Raises $3M From Angels to Boost Cancer Drug Hit Rate
Seattle-based Presage Biosciences has a big dream for a biotech startup—and now it has seed capital to put that dream to the test. Presage, a spinoff from the Fred Hutchinson Cancer Research Center, is announcing today it has raised $3.1 million from angel investors to get the company off the ground at a $5 million … Continue reading “Presage, a Hutch Spinoff, Raises $3M From Angels to Boost Cancer Drug Hit Rate”
Ischemix Faces Moment of Truth with Mid-Stage Heart Drug Trial
Ischemix is facing the biggest hurdle in its 11-year history. The Maynard, MA-based biotech firm is launching the first human study to test the effectiveness of its drug that’s supposed to protect heart tissue from injuries that often occur when blood flow is restored in cardiac surgeries. The drug, called CMX-2043, is the only contender … Continue reading “Ischemix Faces Moment of Truth with Mid-Stage Heart Drug Trial”
From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO
You’ve got the vision, the core team, and even a little money. You’re prepared to devote enormous time and energy to your new startup. You’re unsure what the future will bring but you want to preserve the possibility of going public some day. Here are 10 things you can do to put your startup on … Continue reading “From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO”
Correlsense Secures $8,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=72bc4f12-4342-4f86-b659-81dfc8230923&Preview=1 Date 3/16/2010 Company Name Correlsense Mailing Address 945 Concord Street Framingham, MA 01701 Company Description Correlsense is the leader in IT Reliability™ software. Correlsense SharePath provides a breakthrough in IT Reliability by enabling both a birds-eye and detailed view of how business transactions perform across the four dimensions (4D) of end-users, … Continue reading “Correlsense Secures $8,000,000 Series B Financing Round”
Presage Biosciences Receives $3,100,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7293e6ba-d13a-4629-a833-4966b9748c92&Preview=1 Date 3/16/2010 Company Name Presage Biosciences Mailing Address Undisclosed Seattle, WA 98101 Company Description Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors. Frustrated by a lack of tools to identify pre-existing resistance to oncology … Continue reading “Presage Biosciences Receives $3,100,000 New Financing Round”